127 related articles for article (PubMed ID: 23240158)
1. [Role of cycloferon and interferon-alphain apoptosis regulation in neuroendocrinal system on aging].
Bazhanova ED
Eksp Klin Farmakol; 2012; 75(10):42-6. PubMed ID: 23240158
[TBL] [Abstract][Full Text] [Related]
2. Apoptosis of hypothalamic neurosecretory cells in stress mice at different stages of ontogenesis.
Abatnina YV; Bazhanova ED; Teplyi DL
Neurosci Behav Physiol; 2006 Jun; 36(5):527-30. PubMed ID: 16645768
[TBL] [Abstract][Full Text] [Related]
3. [Apoptosis of the hypothalamus neurosecretory cells in stress and ageing: the role of immune modulators].
Bazhanova ED
Ross Fiziol Zh Im I M Sechenova; 2012 Apr; 98(4):542-50. PubMed ID: 22834344
[TBL] [Abstract][Full Text] [Related]
4. [Hypothalamic neurosecretory cell apoptosis during stress in mice at different stages of ontogenesis].
Abatnina IuV; Bazhanova ED; Teplyĭ DL
Morfologiia; 2005; 127(3):27-9. PubMed ID: 16381307
[TBL] [Abstract][Full Text] [Related]
5. [Cycloferon: mechanism of action, functions and application].
Bazhanova ED
Eksp Klin Farmakol; 2012; 75(7):40-4. PubMed ID: 23025052
[TBL] [Abstract][Full Text] [Related]
6. [Individual changes of gene expression in the interferon system in human blood cells due to amixin and cycloferon].
Sokolova TM; Uryvaev LV; Tazulakhova EB; Ershov FI; Malyshenkova IK; Didkovskiĭ NA
Vopr Virusol; 2005; 50(2):32-6. PubMed ID: 15881395
[TBL] [Abstract][Full Text] [Related]
7. [Changes in expression of apoptosis-associated molecules in hypothalamic neurosecretory cells of mice during aging].
Bazhanova ED; Molodtsov VN; Pavlov KI
Morfologiia; 2006; 130(6):35-9. PubMed ID: 17338214
[TBL] [Abstract][Full Text] [Related]
8. [Intracellular localization of cycloferon, its binding with DNA and stimulation of cytokines expression after exposure to cycloferon].
Kovalenko AL; Kazakov VI; Slita AV; Zarubaev VV; Sukhinin VP
Tsitologiia; 2000; 42(7):659-64. PubMed ID: 10994082
[TBL] [Abstract][Full Text] [Related]
9. [Cycloferon therapy of cytomegalovirus infection in monkeys].
Mezentseva MV; Agrba VZ; Karal-ogly DD; Agumava AA
Eksp Klin Farmakol; 2012; 75(12):37-40. PubMed ID: 23700668
[TBL] [Abstract][Full Text] [Related]
10. [Evaluation of safety and pharmacotherapeutic efficacy of cycloferon in treatment of Astrakhan rickettsial fever].
sherysheva IuV; Galimzianov KhM; Kovalenko AL
Antibiot Khimioter; 2012; 57(1-2):26-31. PubMed ID: 22741199
[TBL] [Abstract][Full Text] [Related]
11. [CYCLOFERON: MECHANISM OF ACTION, AND NEW PROSPECTS FOR APPLICATION IN CLINICAL PRACTICE].
Isakov DV; Isakov VA
Klin Med (Mosk); 2015; 93(9):46-51. PubMed ID: 27008743
[TBL] [Abstract][Full Text] [Related]
12. [Pharmacological correction of alterations of apoptosis of the neurons of the hypothalamus suprachiasmatic nucleus and pinealocytes during aging and stress.].
Khuzhakhmetova LK; Teply DL; Bazhanova ED
Adv Gerontol; 2019; 32(6):915-922. PubMed ID: 32160429
[TBL] [Abstract][Full Text] [Related]
13. [Dose-dependent interferon-induction activity and pharmacokinetics of cycloferon in healthy humans].
Sukhanov DS; Romantsov MG; Smagina AN; Kovalenko AL; Lokteva OM
Eksp Klin Farmakol; 2012; 75(1):23-6. PubMed ID: 22442959
[TBL] [Abstract][Full Text] [Related]
14. [Influence of cycloferon on the biological properties of bacterial intracellular pathogens].
Bukharin OV; Kirillov DA; Sheenkov NV; Kirillov VA
Zh Mikrobiol Epidemiol Immunobiol; 2005; (3):8-10. PubMed ID: 16028504
[TBL] [Abstract][Full Text] [Related]
15. [An experimental study of the efficiency of cycloferon in the complex chemotherapy of generalized drug-resistant tuberculosis].
Sukhanov DS; Vinogradova TI; Demidik SN; El'kin AV; Zabolotnykh NV; Vasil'eva SN; Vitovskaia ML; Romantsov MG
Eksp Klin Farmakol; 2012; 75(9):32-6. PubMed ID: 23156086
[TBL] [Abstract][Full Text] [Related]
16. [Effectiveness of immunomodulating therapy of pulmonary tuberculosis with cycloferon].
Kolomiets VM; Rubleva NV
Klin Med (Mosk); 2013; 91(5):56-9. PubMed ID: 24159790
[TBL] [Abstract][Full Text] [Related]
17. [Cycloferon efficacy in viral and bacterial diseases of children (clinical review)].
Romantsov MG; Goryacheva LG; Bekhtereva MK; Sologub TV; Kovalenko AL
Antibiot Khimioter; 2010; 55(11-12):39-51. PubMed ID: 21574424
[TBL] [Abstract][Full Text] [Related]
18. [Clinical efficacy of the immunomodulatory agent cycloferon (tablets) in viral respiratory infections: Results of a systematic review and meta-analysis].
Mazina NK; Sheshunov IV; Mazin PV; Mazin VP; Kovalenko AL; Zaplutanov VA
Ter Arkh; 2017; 89(11):84-92. PubMed ID: 29260751
[TBL] [Abstract][Full Text] [Related]
19. [THE USE OF CYCLOFERON FOR THE TREATMENT AND PREVENTION OF INFLUENZA AND ACUTE RESPIRATORY VIRAL INFECTIONS].
Alimbarova L
Klin Med (Mosk); 2015; 93(3):57-63. PubMed ID: 26168605
[TBL] [Abstract][Full Text] [Related]
20. [Acridonacetic acid: pharmacological properties and clinical use].
Kovalenko AL; Romantsev MG; Ershov FI
Zh Mikrobiol Epidemiol Immunobiol; 2000; (5):103-8. PubMed ID: 11220949
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
